MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05954nam a22005175i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
TR-AnTOB |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231109085730.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220908s2022 sz | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783031080456 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/978-3-031-08045-6 |
| Source of number or code |
doi |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
TR-AnTOB |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
TR-AnTOB |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
İngilizce |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WC 506 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MJ |
| Source |
bicssc |
|
|---|
| Subject category code |
MED045000 |
| Source |
bisacsh |
|
|---|
| Subject category code |
MJ |
| Source |
thema |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
|---|
| Classification number |
WC506EBK |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Frontiers of COVID-19 |
| Medium |
[electronic resource] : |
| Remainder of title |
Scientific and Clinical Aspects of the Novel Coronavirus 2019 / |
| Statement of responsibility, etc. |
edited by Sasan Adibi, Paul Griffin, Melvin Sanicas, Maryam Rashidi, Francesco Lanfranchi. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st ed. 2022. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Cham : |
| Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
| -- |
Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section I. History, Epidemiologic Background and Pathogenesis of Coronavirus -- Chapter 01: Surfaces as a source for SARS-CoV-2 transmission -- Chapter 02: Humoral immune response in SARS-CoV-2 infection & its therapeutic relevance -- Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system -- Chapter 04: Genetics and Biological characteristics of SARS-CoV-2 -- Chapter 05: COVID-19 impact on host at pathophysiological and cellular level -- Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design -- Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies -- Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2 -- Chapter 09: Emergence of COVID-19 variants and its global impact -- Section II. Clinical Observations -- Chapter 10: Psychological Impacts of the COVID-19 Pandemic -- Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications -- Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19 -- Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic -- Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines -- Chapter 15: Post COVID-19 conditions-the new challenge to mankind -- Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials -- Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours -- Chapter 18: Neurological Complications of COVID-19 -- Chapter 19: The Impact of Covid-19 on Surgical Disease -- Section III. Interventions and Treatments -- Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective -- Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19 -- Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19 -- Section IV. Current Trends and Future Directions -- Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy -- Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges -- Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms -- Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination -- Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !? -- Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021 -- Chapter 29: The Global Evolution of Clinical Practice During a Pandemic -- Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19 -- Chapter 31. The road ahead. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of “herd immunity” and explore the current vaccine trials taking place in different countries. This comprehensive book will illuminate recent advances regarding COVID-19 and offer a possible roadmap on how to move forward. Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Internal medicine. |
|
|---|
| Topical term or geographic name entry element |
Diseases. |
|
|---|
| Topical term or geographic name entry element |
Internal Medicine. |
|
|---|
| Topical term or geographic name entry element |
Diseases. |
| 653 #0 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
COVID-19 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Adibi, Sasan. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Griffin, Paul. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Sanicas, Melvin. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Rashidi, Maryam. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Lanfranchi, Francesco. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-031-08045-6">https://doi.org/10.1007/978-3-031-08045-6</a> |
| Materials specified |
Springer eBooks |
| Public note |
Online access link to the resource |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
National Library of Medicine |
| Koha item type |
E-Book |
